Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4544971
Max Phase: Preclinical
Molecular Formula: C169H274N42O59
Molecular Weight: 3838.29
Molecule Type: Unknown
Associated Items:
ID: ALA4544971
Max Phase: Preclinical
Molecular Formula: C169H274N42O59
Molecular Weight: 3838.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
Standard InChI: InChI=1S/C169H274N42O59/c1-83(2)64-109(200-164(266)135(93(16)220)206-141(243)90(13)184-162(264)134(92(15)219)209-158(260)120(80-216)204-153(255)113(68-87(9)10)198-147(249)105(54-59-131(236)237)191-157(259)119(79-215)202-139(241)88(11)182-124(226)56-51-107(167(269)270)186-123(225)41-33-31-29-27-25-23-21-19-20-22-24-26-28-30-32-34-42-128(230)231)142(244)178-73-125(227)185-101(38-35-61-176-168(171)172)144(246)195-111(66-85(5)6)151(253)203-118(78-214)155(257)183-89(12)140(242)189-103(52-57-129(232)233)145(247)196-110(65-84(3)4)150(252)199-114(71-98-72-175-82-181-98)154(256)190-104(53-58-130(234)235)146(248)197-112(67-86(7)8)152(254)205-121(81-217)159(261)210-137(95(18)222)165(267)201-115(70-97-45-49-100(224)50-46-97)166(268)211-63-37-40-122(211)160(262)192-102(39-36-62-177-169(173)174)148(250)208-136(94(17)221)163(265)193-106(55-60-132(238)239)149(251)207-133(91(14)218)161(263)180-75-127(229)187-116(76-212)143(245)179-74-126(228)188-117(77-213)156(258)194-108(138(170)240)69-96-43-47-99(223)48-44-96/h43-50,72,82-95,101-122,133-137,212-224H,19-42,51-71,73-81H2,1-18H3,(H2,170,240)(H,175,181)(H,178,244)(H,179,245)(H,180,263)(H,182,226)(H,183,257)(H,184,264)(H,185,227)(H,186,225)(H,187,229)(H,188,228)(H,189,242)(H,190,256)(H,191,259)(H,192,262)(H,193,265)(H,194,258)(H,195,246)(H,196,247)(H,197,248)(H,198,249)(H,199,252)(H,200,266)(H,201,267)(H,202,241)(H,203,253)(H,204,255)(H,205,254)(H,206,243)(H,207,251)(H,208,250)(H,209,260)(H,210,261)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H,238,239)(H,269,270)(H4,171,172,176)(H4,173,174,177)/t88-,89-,90-,91+,92+,93+,94+,95+,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,133-,134-,135-,136-,137-/m0/s1
Standard InChI Key: JQENMIHVVBTWDQ-ZRFHBHASSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 3838.29 | Molecular Weight (Monoisotopic): 3835.9731 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2017) Amylin and calcitonin receptor agonist, |
Source(1):